Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 1 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

INDUSTRY 8OTHER 5NETWORK 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

pembrolizumab 1niraparib 1durvalumab 1cabozantinib 1Radiotherapy 1Radiation Dose Hypofractionation 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × Urothelial Cancer × Clear all
NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el CÔncer

Phase 1/2 Completed
67 enrolled
Genitourinary

Urothelial Cancer

NCT02891161 2024-11-27

DUART

Big Ten Cancer Research Consortium

Phase 1/2 Terminated
26 enrolled 20 charts
Genitourinary

Urothelial Cancer

NCT04131634 2021-06-16

SAbR

University of Texas Southwestern Medical Center

Phase 2 Terminated
2 enrolled
Genitourinary

Urothelial Cancer

NCT02880345 2019-04-23

RADVAXā„¢: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 Monotherapy

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn
Genitourinary

Urothelial Cancer

NCT01801137 2016-06-21

AFINIVEST

Hopital Foch

Phase 2 Completed
54 enrolled
Genitourinary

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚔